L2 Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

L2 Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.58M	Buy	+27,290	New	+$5.98M	0.68%	49
2021 Q1	–	Sell	-4,922	Closed	-$812K	–	86
2020 Q4	$812K	Sell	4,922 -660	-12%	-$98.3K	0.56%	53
2020 Q3	$796K	Sell	5,582 -2,359	-30%	-$292K	0.64%	47
2020 Q2	$876K	Sell	7,941 -1,359	-15%	-$150K	0.79%	44
2020 Q1	$928K	Sell	9,300 -1,940	-17%	-$251K	1.04%	36
2019 Q4	$1.68M	Buy	+11,240	New	+$1.53M	1.47%	32

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

L2 Asset Management's JAZZ Position: Q2 2026 in Review

L2 Asset Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 27,290 shares worth $6.58M. The stake represents 0.68% of the portfolio and ranks #49 among its holdings. This is a return to the name: L2 Asset Management previously reported a position in JAZZ as recently as Q4 2020.

L2 Asset Management first reported a position in JAZZ in Q4 2019 and has held it in 6 quarters since. 643 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

L2 Asset Management held 27,290 shares of Jazz Pharmaceuticals worth $6.58M as of Q2 2026.
Jazz Pharmaceuticals was a new L2 Asset Management position in Q2 2026.
Jazz Pharmaceuticals made up 0.68% of L2 Asset Management's portfolio in Q2 2026, its #49 holding.
L2 Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2019 and has held it in 6 quarters since.
643 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on L2 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.